1887

Abstract

Many bacterial infections are associated with biofilm formation. In the urinary tract bacterial biofilms develop on both living surfaces and artificial implants, producing chronic and often intractable infections. is the most common organism associated with urinary tract infections. In contrast to uropathogenic (UPEC), which cause symptomatic urinary tract infection, asymptomatic bacteriuria (ABU) strains are associated with essentially symptom-free infections. Here the biofilm-forming capacity on abiotic surfaces of selected ABU strains and UPEC strains in human urine was investigated. It was found that there is a strong bias for biofilm formation by the ABU strains. Not only were the ABU strains significantly better biofilm formers than UPEC strains, they were also able to out-compete UPEC strains as well as uropathogenic strains of spp. during biofilm formation. The results support the notion of bacterial prophylaxis employing selected ABU strains to eliminate UPEC strains and other pathogens in patients prone to recalcitrant infections.

Loading

Article metrics loading...

/content/journal/micro/10.1099/mic.0.2006/004721-0
2007-06-01
2019-09-24
Loading full text...

Full text loading...

/deliver/fulltext/micro/153/6/1711.html?itemId=/content/journal/micro/10.1099/mic.0.2006/004721-0&mimeType=html&fmt=ahah

References

  1. Anderson, G. G., Palermo, J. J., Schilling, J. D., Roth, R., Heuser, J. & Hultgren, S. J. ( 2003; ). Intracellular bacterial biofilm-like pods in urinary tract infections. Science 301, 105–107.[CrossRef]
    [Google Scholar]
  2. Brzuszkiewicz, E., Brüggemann, H., Liesegang, H., Emmerth, M., Ölschläger, T., Nagy, G., Albermann, K., Wagner, C., Buchrieser, C. & other authors ( 2006; ). How to become a uropathogen: comparative genomic analysis of extraintestinal pathogenic Escherichia coli strains. Proc Natl Acad Sci U S A 103, 12879–12884.[CrossRef]
    [Google Scholar]
  3. Christensen, B. B., Sternberg, C., Andersen, J. B., Palmer, R. J., Jr, Nielsen, A. T., Givskov, M. & Molin, S. ( 1999; ). Molecular tools for study of biofilm physiology. Methods Enzymol 310, 20–42.
    [Google Scholar]
  4. Costerton, J. W., Lewandowski, Z., Caldwell, D. E., Korber, D. R. & Lappin-Scott, H. M. ( 1995; ). Microbial biofilms. Annu Rev Microbiol 49, 711–745.[CrossRef]
    [Google Scholar]
  5. Costerton, J. W., Stewart, P. S. & Greenberg, E. P. ( 1999; ). Bacterial biofilms: a common cause of persistent infections. Science 284, 1318–1322.[CrossRef]
    [Google Scholar]
  6. Darouiche, R. O., Donovan, W. H., Del Terzo, M., Thornby, J. I., Rudy, D. C. & Hull, R. A. ( 2001; ). Pilot trial of bacterial interference for preventing urinary tract infection. Urology 58, 339–344.[CrossRef]
    [Google Scholar]
  7. Darouiche, R. O., Thornby, J. I., Cerra-Stewart, C., Donovan, W. H. & Hull, R. A. ( 2005; ). Bacterial interference for prevention of urinary tract infection: a prospective, randomized, placebo-controlled, double-blind pilot trial. Clin Infect Dis 41, 1531–1534.[CrossRef]
    [Google Scholar]
  8. Diederich, L., Rasmussen, L. J. & Messer, W. ( 1992; ). New cloning vectors for integration into the lambda attachment site attB of the Escherichia coli chromosome. Plasmid 28, 14–24.[CrossRef]
    [Google Scholar]
  9. Dyer, I. E., Sankary, T. M. & Dawson, J. A. ( 1998; ). Antibiotic resistance in bacterial urinary tract infections, 1991 to 1997. West J Med 169, 265–268.
    [Google Scholar]
  10. Foxman, B. ( 2002; ). Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med 113 (Suppl. 1A), 5S–13S.
    [Google Scholar]
  11. Gales, A. C., Jones, R. N., Gordon, K. A., Sader, H. S., Wilke, W. W., Beach, M. L., Pfaller, M. A. & Doern, G. V. ( 2000; ). Activity and spectrum of 22 antimicrobial agents tested against urinary tract infection pathogens in hospitalized patients in Latin America: report from the second year of the SENTRY Antimicrobial Surveillance Program (1998) J Antimicrob Chemother 45, 295–303.[CrossRef]
    [Google Scholar]
  12. Gupta, K., Scholes, D. & Stamm, W. E. ( 1999; ). Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women. JAMA 281, 736–738.[CrossRef]
    [Google Scholar]
  13. Gupta, K., Sahm, D. F., Mayfield, D. & Stamm, W. E. ( 2001; ). Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in women: a nationwide analysis. Clin Infect Dis 33, 89–94.[CrossRef]
    [Google Scholar]
  14. Hancock, V., Ferrières, L. & Klemm, P. ( 2007; ). Biofilm formation by asymptomatic and virulent urinary tract infectious Escherichia coli strains. FEMS Microbiol Lett 267, 30–37.[CrossRef]
    [Google Scholar]
  15. Hansson, S., Jodal, U., Lincoln, K. & Svanborgeden, C. ( 1989; ). Untreated aymptomatic bacteriuria in girls. II. Effect of phenoxymethylpenicillin and erythromycin given for intercurrent infections. BMJ 298, 856–859.[CrossRef]
    [Google Scholar]
  16. Hull, R. A., Gill, R. E., Hsu, P., Minshew, B. H. & Falkow, S. ( 1981; ). Construction and expression of recombinant plasmids encoding type 1 or d-mannose-resistant pili from a urinary tract infection Escherichia coli isolate. Infect Immun 33, 933–938.
    [Google Scholar]
  17. Hull, R., Rudy, D., Donovan, W., Svanborg, C., Wieser, I., Stewart, C. & Darouiche, R. ( 2000; ). Urinary tract infection prophylaxis using Escherichia coli 83972 in spinal cord injured patients. J Urol 163, 872–877.[CrossRef]
    [Google Scholar]
  18. Hultgren, S. J., Schwan, W. R., Schaeffer, A. J. & Duncan, J. L. ( 1986; ). Regulation of production of type 1 pili among urinary tract isolates of Escherichia coli. Infect Immun 54, 613–620.
    [Google Scholar]
  19. Lindberg, U., Hanson, L. A., Jodal, U., Lidin-Janson, G., Lincoln, K. & Olling, S. ( 1975; ). Asymptomatic bacteriuria in schoolgirls. II. Differences in Escherichia coli causing asymptomatic bacteriuria. Acta Paediatr Scand 64, 432–436.[CrossRef]
    [Google Scholar]
  20. Lindberg, U., Claesson, I., Hanson, L. A. & Jodal, U. ( 1978; ). Asymptomatic bacteriuria in schoolgirls. VIII. Clinical course during a 3-year follow-up. J Pediatr 92, 194–199.[CrossRef]
    [Google Scholar]
  21. Luzzaro, F., Mezzatesta, M., Mugnaioli, C., Perilli, M., Stefani, S., Amicosante, G., Rossolini, G. M. & Toniolo, A. ( 2006; ). Trends in production of extended-spectrum beta-lactamases among enterobacteria of medical interest: report of the second Italian nationwide survey. J Clin Microbiol 44, 1659–1664.[CrossRef]
    [Google Scholar]
  22. Manges, A. R., Johnson, J. R., Foxman, B., O'Bryan, T. T., Fullerton, K. E. & Riley, L. W. ( 2001; ). Widespread distribution of urinary tract infections caused by a multidrug-resistant Escherichia coli clonal group. N Engl J Med 345, 1007–1013.[CrossRef]
    [Google Scholar]
  23. Marild, S., Jodal, U., Orskov, I., Orskov, F. & Svanborg-Eden, C. ( 1989; ). Special virulence of the Escherichia coli O1 : K1 : H7 clone in acute pyelonephritis. J Pediatr 115, 40–45.[CrossRef]
    [Google Scholar]
  24. Reid, G., Denstedt, J. D., Kang, Y. S., Lam, D. & Nause, C. ( 1992; ). Microbial adhesion and biofilm formation on ureteral stents in vitro and in vivo. J Urol 148, 1592–1594.
    [Google Scholar]
  25. Reid, G., Howard, J. & Gan, B. S. ( 2001; ). Can bacterial interference prevent infection?. Trends Microbiol 9, 424–428.[CrossRef]
    [Google Scholar]
  26. Reisner, A., Molin, S. & Zechner, E. L. ( 2002; ). Recombinant engineering of conjugative plasmids with fluorescent marker cassettes. FEMS Microbiol Ecol 42, 251–259.[CrossRef]
    [Google Scholar]
  27. Ronald, A. ( 2003; ). The etiology of urinary tract infection: traditional and emerging pathogens. Dis Mon 49, 71–82.[CrossRef]
    [Google Scholar]
  28. Roos, V., Nielsen, E. M. & Klemm, P. ( 2006a; ). Asymptomatic bacteriuria Escherichia coli strains: adhesins, growth and competition. FEMS Microbiol Lett 262, 22–30.[CrossRef]
    [Google Scholar]
  29. Roos, V., Ulett, G. C., Schembri, M. A. & Klemm, P. ( 2006b; ). The asymptomatic bacteriuria Escherichia coli strain 83972 out-competes UPEC strains in human urine. Infect Immun 74, 615–624.[CrossRef]
    [Google Scholar]
  30. Stamm, W. E. & Norrby, S. R. ( 2001; ). Urinary tract infections: disease panorama and challenges. J Infect Dis 183 (Suppl. 1), S1–S4.[CrossRef]
    [Google Scholar]
  31. Struve, C. & Krogfelt, K. A. ( 2003; ). Role of capsule in Klebsiella pneumoniae virulence: lack of correlation between in vitro and in vivo studies. FEMS Microbiol Lett 218, 149–154.[CrossRef]
    [Google Scholar]
  32. Trautner, B. W., Darouiche, R. O., Hull, R. A., Hull, S. & Thornby, J. I. ( 2002; ). Pre-inoculation of urinary catheters with Escherichia coli 83972 inhibits catheter colonization by Enterococcus faecalis. J Urol 167, 375–379.[CrossRef]
    [Google Scholar]
  33. Trautner, B. W., Hull, R. A. & Darouiche, R. O. ( 2003; ). Escherichia coli 83972 inhibits catheter adherence by a broad spectrum of uropathogens. Urology 61, 1059–1062.[CrossRef]
    [Google Scholar]
  34. Vranes, J., Kruzic, V., Sterk-Kuzmanovic, N. & Schonwald, S. ( 2003; ). Virulence characteristics of Escherichia coli strains causing asymptomatic bacteriuria. Infection 31, 216–220.
    [Google Scholar]
  35. Warren, J. W. ( 2001; ). Catheter-associated urinary tract infections. Int J Antimicrob Agents 17, 299–303.[CrossRef]
    [Google Scholar]
  36. Welch, R. A., Burland, V., Plunkett, G., III, Redford, P., Roesch, P., Rasko, D., Buckles, E. L., Liou, S. R., Boutin, A. & other authors ( 2002; ). Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli. Proc Natl Acad Sci U S A 99, 17020–17024.[CrossRef]
    [Google Scholar]
  37. Wilson, M. L. & Gaido, L. ( 2004; ). Laboratory diagnosis of urinary tract infections in adult patients. Clin Infect Dis 38, 1150–1158.[CrossRef]
    [Google Scholar]
  38. Yuksel, S., Özturk, B., Kavaz, A., Özcakar, B., Acar, B., Guriz, H., Aysev, D., Ekim, M. & Yalcmkaya, F. ( 2006; ). Antibiotic resistance of urinary tract pathogens and evaluation of empirical treatment in Turkish children with urinary tract infections. Int J Antimicrob Agents 28, 413–416.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/micro/10.1099/mic.0.2006/004721-0
Loading
/content/journal/micro/10.1099/mic.0.2006/004721-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error